IPIE
Intelligent Assessment of Pharmaceutical in the Environment
| Coordinator | ECT OEKOTOXIKOLOGIE GMBH ; TEVA PHARMACEUTICALS EUROPE B.V. ; Eli Lilly and Company Limited ; JANSSEN PHARMACEUTICA NV ; Helmholtz-Zentrum für Umweltforschung GmbH - UFZ ; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. ; STICHTING KATHOLIEKE UNIVERSITEIT ; Pompeu Fabra University ; German Federal Environment Agency ; University of Exeter ; Roche (Switzerland) ; BAYER AKTIENGESELLSCHAFT ; MERCK SHARP & DOHME CORP ; SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT ; Bristol Myers Squibb Company ; FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM ; Liverpool John Moores University ; Boehringer Ingelheim Fonds ; University of York ; Novartis Pharma Ltd ; MOLECULAR NETWORKS GMBH COMPUTERCHEMIE ; Lhasa Limited ; SYNAPSE RESEARCH MANAGEMENT PARTNERS SL ; ASTRAZENECA AB ; PFIZER LIMITED |
| Grant period | 2015-01-01 - 2019-06-30 |
| Funding body | European Union |
| Call number | IMI-JU-11-2013 |
| Grant number | 115735 |
| Identifier | G:(EU-Grant)115735 |